Kun-Hsing Yu, MD, PhD
Kun-Hsing Yu, MD, PhD
Assistant Professor of Biomedical Informatics, Harvard Medical School

Kun-Hsing "Kun" Yu received his PhD in Biomedical Informatics and PhD Minor in Computer Science from Stanford University, and he obtained his MD from National Taiwan University, Taiwan. His research focuses on the integration of quantitative histopathology image patterns with multi-omics (genomics, epigenomics, transcriptomics, and proteomics) profiles to advance cancer research and clinical practice. His team has developed fully-automated algorithms to analyze whole-slide histopathology images at scale, discovered the molecular mechanisms underpinning the microscopic phenotypes of tumor cells, and identified novel cellular morphologies for patient prognosis. His research interests include quantitative pathology, machine learning, and translational bioinformatics.

DBMI Research Areas
DBMI Courses
Current Postdoctoral Fellowship Opportunities
Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types.
Authors: Wang F, Yang S, Palmer N, Fox K, Kohane IS, Liao KP, Yu KH, Kou SC.
NPJ Precis Oncol
View full abstract on Pubmed
Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma.
Authors: Marostica E, Barber R, Denize T, Kohane IS, Signoretti S, Golden JA, Yu KH.
Clin Cancer Res
View full abstract on Pubmed
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
Authors: Wongvibulsin S, Pahalyants V, Kalinich M, Murphy W, Yu KH, Wang F, Chen ST, Reynolds K, Kwatra SG, Semenov YR.
J Am Acad Dermatol
View full abstract on Pubmed
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA.
Authors: Kalinich M, Murphy W, Wongvibulsin S, Pahalyants V, Yu KH, Lu C, Wang F, Zubiri L, Naranbhai V, Gusev A, Kwatra SG, Reynolds KL, Semenov YR.
J Immunother Cancer
View full abstract on Pubmed
Temporal bias in case-control design: preventing reliable predictions of the future.
Authors: Yuan W, Beaulieu-Jones BK, Yu KH, Lipnick SL, Palmer N, Loscalzo J, Cai T, Kohane IS.
Nat Commun
View full abstract on Pubmed
Prolonged Auditory Brainstem Response in Universal Hearing Screening of Newborns with Autism Spectrum Disorder.
Authors: Miron O, Delgado RE, Delgado CF, Simpson EA, Yu KH, Gutierrez A, Zeng G, Gerstenberger JN, Kohane IS.
Autism Res
View full abstract on Pubmed
Deep decision support for lymph node metastatic risk evaluation.
Authors: Marostica E, Yu KH.
View full abstract on Pubmed
Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networks.
Authors: Yu KH, Hu V, Wang F, Matulonis UA, Mutter GL, Golden JA, Kohane IS.
View full abstract on Pubmed
Reproducible Machine Learning Methods for Lung Cancer Detection Using Computed Tomography Images: Algorithm Development and Validation.
Authors: Yu KH, Lee TM, Yen MH, Kou SC, Rosen B, Chiang JH, Kohane IS.
J Med Internet Res
View full abstract on Pubmed
Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
Authors: Yu KH, Wang F, Berry GJ, Ré C, Altman RB, Snyder M, Kohane IS.
J Am Med Inform Assoc
View full abstract on Pubmed